VIR Vir Biotechnology, Inc.

Fundamentals / CIK 0001706431 / USD

Vir Biotechnology, Inc. reported $302.8M in revenue and a net loss of $184.8M for the trailing twelve months ended September 30, 2026 (down 178.3% year over year), with a 22.6% gross margin and a -69.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VIR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$1.66B$828.7M$0-$712.4MFY 2017 Revenue: $2.71MFY 2017 Net Income: -$69.85M2017FY 2018 Revenue: $10.67MFY 2018 Net Income: -$115.9M2018FY 2019 Revenue: $8.09MFY 2019 Net Income: -$174.7M2019FY 2020 Revenue: $76.37MFY 2020 Net Income: -$298.7M2020FY 2021 Revenue: $1.10BFY 2021 Net Income: $528.6M2021FY 2022 Revenue: $1.62BFY 2022 Net Income: $515.8M2022FY 2023 Revenue: $86.18MFY 2023 Net Income: -$615.1M2023FY 2024 Revenue: $74.20MFY 2024 Net Income: -$522.0M2024FY 2025 Revenue: $68.56MFY 2025 Net Income: -$438.0M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $68.56M $74.20M $86.18M $1.62B $1.10B $76.37M $8.09M $10.67M $2.71M
Cost of Revenue $26K $845K $2.77M $146.3M $65.86M $0 $0 -- --
Gross Profit $68.53M $73.36M $83.42M $1.47B $1.03B $76.37M $8.09M -- --
Research & Development $456.0M $506.5M $579.7M $474.6M $448.0M $302.4M $148.5M $100.2M $62.51M
Selling, General & Admin $92.07M $119.0M $174.4M $161.8M $160.8M $70.94M $37.60M -- --
Total Operating Expenses -- -- -- -- -- $373.3M $186.1M $129.4M $84.20M
Operating Income -$479.3M -$587.2M -$684.3M $833.1M $420.8M -$297.0M -$178.0M -$118.7M -$81.50M
EBITDA -$467.6M -$572.6M -$664.9M $839.9M $426.0M -$292.6M -$174.7M -$117.1M -$81.24M
Interest Income $40.24M $71.81M $86.99M $28.09M -- -- $8.51M $2.54M $638K
Income Before Tax -$437.8M -$523.1M -$628.2M $754.3M $549.8M -$298.6M -$174.5M -$116.4M -$80.78M
Income Tax Expense $217K -$1.15M -$13.08M $238.4M $21.22M $54K $154K -$480K -$10.92M
Net Income -$438.0M -$522.0M -$615.1M $515.8M $528.6M -$298.7M -$174.7M -$115.9M -$69.85M
Basic EPS -$3.16 -$3.83 -$4.59 $3.89 $4.07 -$2.51 -$5.76 -$15.12 -$32.45
Diluted EPS -$3.16 -$3.83 -$4.59 $3.83 $3.96 -$2.51 -$5.76 -$15.12 -$32.45
Basic Shares Outstanding 138.5M 136.2M 134.1M 132.6M 129.9M 119.2M 30.3M 7.7M 2.2M
Diluted Shares Outstanding 138.5M 136.2M 134.1M 134.8M 133.4M 119.2M 30.3M 7.7M 2.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -$188K $238.9M -$29K $64.07M $240K $1.21M $3.03M $12.37M
Cost of Revenue -- $0 -- -- -- $11K $0 $684K
Gross Profit -- $238.9M -- -- -- $1.20M $3.03M $11.69M
Research & Development $80.04M $135.3M $108.9M $88.35M $151.5M $97.51M $118.6M $106.1M
Selling, General & Admin $24.43M $30.20M $23.34M $23.62M $22.23M $22.28M $23.94M $26.70M
Operating Income -$104.7M $73.47M -$132.3M -$47.92M -$173.4M -$118.4M -$139.5M -$117.2M
EBITDA -$101.9M $76.27M -$129.5M -$45.02M -$170.4M -$115.5M -$136.7M -$114.3M
Interest Income $9.32M $8.97M $7.19M $7.80M $9.36M $10.79M $12.29M $14.15M
Income Before Tax -$96.39M $80.26M -$125.5M -$43.06M -$163.0M -$110.8M -$120.9M -$104.7M
Income Tax Expense -$143K $179K $170K -$137K $168K $170K $16K -$86K
Net Income -$96.25M $80.08M -$125.7M -$42.92M -$163.1M -$111.0M -$121.0M -$104.6M
Basic EPS -$0.57 $0.48 -$0.85 -- -$1.17 -$0.80 -$0.88 --
Diluted EPS -$0.57 $0.47 -$0.85 -- -$1.17 -$0.80 -$0.88 --
Basic Shares Outstanding 169.3M 167.7M 147.4M -- 138.9M 138.4M 137.5M --
Diluted Shares Outstanding 169.3M 168.9M 147.4M -- 138.9M 138.4M 137.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $232.2M $222.9M $241.6M $848.6M $347.8M $436.6M $109.3M $47.60M
Short-Term Investments $228.8M $678.1M $1.27B $1.52B $217.2M $300.3M $274.1M $50.84M
Cash & Short-Term Investments $460.9M $901.0M $1.63B $2.40B $909.5M $736.9M $383.4M $98.44M
Accounts Receivable, Net -- -- -- $0 $773.1M $0 -- --
Other Current Assets -- $100K $7.60M $26.40M -- -- -- --
Total Current Assets $514.1M $1.04B $1.59B $2.52B $1.56B $772.4M $403.0M $117.8M
Property, Plant & Equipment, Net $55.62M $63.18M $96.02M $105.6M $42.83M $17.95M $16.31M $12.29M
Goodwill $16.94M $16.94M $16.94M $16.94M $16.94M $16.94M $16.94M $16.94M
Intangible Assets $7.85M $8.12M $22.57M $32.76M $33.29M $33.82M $35.69M $36.92M
Long-Term Investments $314.6M $190.0M $105.3M $23.93M $201.4M $0 $24.29M --
Total Non-Current Assets $488.7M $356.4M $330.8M $283.0M $391.4M $146.4M $109.1M $73.81M
Total Assets $1.00B $1.40B $1.92B $2.80B $1.95B $918.8M $512.1M $191.6M
Accounts Payable $9.80M $5.08M $6.33M $6.42M $6.52M $5.08M $5.88M $6.47M
Deferred Revenue (Current) $0 $12.65M $64.85M $15.52M $98.21M $6.45M $6.18M $8.76M
Total Current Liabilities $92.81M $119.7M $175.4M $511.0M $341.2M $99.06M $59.21M $39.91M
Deferred Revenue (Non-Current) -- $0 $1.53M $53.21M $3.81M $3.81M $12.67M $6.56M
Other Non-Current Liabilities $21.58M $14.58M $15.78M $11.12M $2.54M $3.85M $3.57M $1.59M
Total Non-Current Liabilities $144.7M $128.8M $153.4M $213.1M $181.2M $102.8M $28.92M $21.73M
Total Liabilities $237.5M $248.4M $328.8M $724.1M $522.4M $201.9M $88.13M $61.64M
Total Debt (incl. Leases) $97.85M $97.89M $124.5M $128.0M $137.5M $71.15M $1.14M --
Common Stock $14K $14K $13K $13K $13K $13K $11K $1.0K
Retained Earnings -$1.20B -$759.8M -$237.8M $377.2M -$138.6M -$667.2M -$368.5M -$193.8M
Accumulated Other Comp. Income -$2.06M -$1.72M -$815K -$9.12M -$1.10M -$1.28M -$601K -$14K
Total Stockholders' Equity $765.3M $1.15B $1.59B $2.08B $1.43B $716.9M $423.9M -$179.2M
Total Equity $765.3M $1.15B $1.59B $2.08B $1.43B $716.9M $423.9M -$179.2M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $218.9M $278.7M $274.2M $232.2M $170.1M $211.1M $273.6M $222.9M
Short-Term Investments $235.8M $249.9M $196.3M $228.8M $327.8M $387.6M $517.4M $678.1M
Cash & Short-Term Investments $454.6M $528.6M $470.4M $460.9M $497.8M $598.7M $790.9M $901.0M
Other Current Assets -- -- -- -- -- -- -- $100K
Total Current Assets $508.3M $573.7M $523.0M $514.1M $545.7M $735.7M $932.2M $1.04B
Property, Plant & Equipment, Net $47.77M $50.43M $53.16M $55.62M $58.20M $60.80M $61.68M $63.18M
Goodwill $16.94M $16.94M $16.94M $16.94M $16.94M $16.94M $16.94M $16.94M
Intangible Assets $7.63M $7.70M $7.78M $7.85M $7.92M $8.00M $8.07M $8.12M
Long-Term Investments $442.9M $475.0M $333.0M $314.6M $304.2M $286.1M $218.1M $190.0M
Total Non-Current Assets $603.6M $641.1M $502.6M $488.7M $473.8M $456.8M $375.5M $356.4M
Total Assets $1.11B $1.21B $1.03B $1.00B $1.02B $1.19B $1.31B $1.40B
Accounts Payable $11.32M $17.75M $5.45M $9.80M $6.85M $12.23M $3.73M $5.08M
Deferred Revenue (Current) -- -- -- $0 $0 $10.11M $11.94M $12.65M
Total Current Liabilities $80.66M $94.96M $73.56M $92.81M $75.22M $105.0M $137.3M $119.7M
Deferred Revenue (Non-Current) -- -- -- -- $9.43M -- -- $0
Other Non-Current Liabilities $20.72M $18.88M $19.42M $21.58M $13.30M $13.03M $14.81M $14.58M
Total Non-Current Liabilities $135.2M $137.4M $139.3M $144.7M $148.1M $140.1M $126.6M $128.8M
Total Liabilities $215.8M $232.3M $212.8M $237.5M $223.4M $245.1M $263.9M $248.4M
Total Debt (incl. Leases) $90.78M $93.27M $95.58M $97.85M $100.2M $102.2M $96.09M $97.89M
Common Stock $17K $17K $16K $14K $14K $14K $14K $14K
Retained Earnings -$1.34B -$1.24B -$1.32B -$1.20B -$1.15B -$991.7M -$880.7M -$759.8M
Accumulated Other Comp. Income -$6.90M -$4.60M -$3.48M -$2.06M -$1.91M -$2.22M -$1.98M -$1.72M
Total Stockholders' Equity $896.0M $982.5M $812.8M $765.3M $796.1M $947.5M $1.04B $1.15B
Total Equity $896.0M $982.5M $812.8M $765.3M $796.1M $947.5M $1.04B $1.15B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$438.0M -$522.0M -$615.1M $515.8M $528.6M -$298.7M -$174.7M -$115.9M -$69.85M
Depreciation & Amortization $11.68M $14.56M $19.45M $6.78M $5.28M $4.40M $3.29M $1.62M $255K
Stock-Based Compensation $49.07M $78.46M $111.3M $102.1M $83.78M $27.60M $8.72M $5.05M $4.78M
Change in Receivables -- -$6.51M -$565K $770.0M -$773.1M $0 -- -- --
Change in Payables $5.00M -$988K $732K $797K -$171K -$790K $964K $1.47M $2.01M
Operating Cash Flow -$391.8M -$446.4M -$778.8M $1.66B -$47.59M -$190.9M -$129.6M -$94.10M -$66.38M
Capital Expenditure -$4.83M -$7.30M -$21.57M -$68.01M -$21.82M -$6.55M -$8.94M -$8.19M -$2.74M
Free Cash Flow -$396.6M -$453.7M -$800.4M $1.60B -$69.41M -$197.5M -$138.6M -$102.3M -$69.12M
Acquisitions, Net -- -- -- -- -- -- -- -- -$27.25M
Purchases of Investments -$886.3M -$1.24B -$2.02B -$1.48B -$420.2M -$403.8M -$643.9M -$123.1M --
Sales & Maturities of Investments $1.20B $1.74B $2.20B $351.5M $301.2M $400.3M $396.7M $72.57M --
Investing Cash Flow $310.4M $499.4M $164.6M -$1.19B -$140.8M -$9.86M -$256.2M -$60.44M -$29.99M
Common Stock Issued -- -- -- $0 $0 $323.2M $126.4M -- --
Financing Cash Flow $3.79M $4.39M $7.48M $34.76M $100.3M $529.5M $449.2M $24.98M $271.2M
Net Change in Cash -$77.62M $57.40M -$606.7M $504.6M -$88.07M $328.7M $63.45M -$129.6M $174.8M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$96.25M $80.08M -$125.7M -$42.92M -$163.1M -$111.0M -$121.0M -$104.6M
Depreciation & Amortization $2.77M $2.80M $2.81M $2.90M $3.00M $2.92M $2.87M $2.89M
Stock-Based Compensation $10.46M $12.39M $12.09M $11.21M $11.36M $12.45M $14.06M $15.84M
Change in Receivables -- -- -- -- -- -- -- -$8.75M
Change in Payables -$6.43M $12.31M -$4.23M $2.96M -$5.40M $8.86M -$1.42M -$1.94M
Operating Cash Flow -$106.1M $123.3M -$132.4M -$25.88M -$167.6M -$120.2M -$78.12M -$87.64M
Capital Expenditure -$34K -$32K -$390K -$348K -$317K -$2.54M -$1.63M -$2.00M
Free Cash Flow -$106.1M $123.3M -$132.8M -$26.22M -$167.9M -$122.8M -$79.75M -$89.63M
Purchases of Investments -$128.5M -$352.1M -$158.4M -$255.8M -$264.4M -$192.4M -$173.7M -$160.9M
Sales & Maturities of Investments $173.1M $155.0M $170.6M $342.9M $305.2M $251.3M $301.9M $301.1M
Investing Cash Flow $44.56M -$197.1M $11.84M $86.65M $40.45M $56.46M $126.8M $140.7M
Common Stock Issued -- -- $162.3M -- -- -- $0 --
Financing Cash Flow $1.63M $78.38M $162.5M $1.04M $102K $2.05M $598K $1.26M
Net Change in Cash -$59.89M $4.56M $41.97M $61.81M -$127.0M -$61.72M $49.30M $54.37M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 100.0% 98.9% 96.8% 90.9% 94.0% 100.0% 100.0% -- --
Operating Margin -699.2% -791.3% -794.0% 51.6% 38.4% -388.9% -2199.7% -1112.6% -3009.5%
Net Profit Margin -638.9% -703.4% -713.7% 31.9% 48.3% -391.1% -2159.0% -1086.3% -2579.5%
Return on Equity (ROE) -57.2% -45.4% -38.7% 24.8% 36.9% -41.7% -41.2% -- --
Return on Assets (ROA) -43.7% -37.3% -32.1% 18.4% 27.0% -32.5% -34.1% -60.5% --
Current Ratio 5.54x 8.71x 9.05x 4.93x 4.58x 7.80x 6.81x 2.95x --
Quick Ratio 4.97x 7.53x 9.29x 4.70x 4.93x 7.44x 6.48x 2.47x --
Debt to Equity 0.13x 0.09x 0.08x 0.06x 0.10x 0.10x 0.00x -- --
Revenue Growth (YoY) -7.6% -13.9% -94.7% +47.5% +1334.4% +843.9% -24.2% +293.9% --
Gross Profit Growth (YoY) -6.6% -12.1% -94.3% +42.7% +1248.1% +843.9% -- -- --
Operating Income Growth (YoY) -- -- -182.1% +98.0% -- -- -- -- --
Net Income Growth (YoY) -- -- -219.2% -2.4% -- -- -- -- --
EPS Growth (YoY) -- -- -218.0% -4.4% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -146.8% -- -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -150.2% -- -- -- -- -- --
5Y Revenue / Share Growth -22.8% +104.3% -53.8% +868.4% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -- -- -- -- -- 96.1% 96.2% 98.9%
Operating Margin -69.8% -92.4% -720.8% -699.2% -3253.6% -3191.7% -3099.7% -791.3%
Net Profit Margin -61.0% -83.0% -676.0% -638.9% -2963.5% -2895.9% -2769.0% -703.4%
Return on Equity (ROE) -20.6% -25.6% -54.5% -57.2% -62.8% -58.1% -55.3% -45.4%
Return on Assets (ROA) -16.6% -20.7% -43.2% -43.7% -49.0% -46.1% -44.2% -37.3%
Current Ratio 6.30x 6.04x 7.11x 5.54x 7.25x 7.01x 6.79x 8.71x
Quick Ratio 5.64x 5.57x 6.40x 4.97x 6.62x 5.70x 5.76x 7.53x
Debt to Equity 0.10x 0.09x 0.12x 0.13x 0.13x 0.11x 0.09x 0.09x
Revenue Growth (YoY) -178.3% +19582.5% -101.0% +417.8% -89.9% -60.5% -94.6% -26.3%
Gross Profit Growth (YoY) -- +19762.5% -- -- -- -60.2% -94.6% -26.9%
Source: SEC EDGAR CompanyFacts (CIK 0001706431) · from December 31, 2017 Data through September 30, 2026 · synced Nov 20, 2026, 05:22 UTC · Open in terminal